Technivie (Ombitasvir / Paritaprevir / Ritonavir)

Brand Options

arrow pointer

Brand Name : Technivie

Marketing Authorization Holder : AbbVie

Prescription Required

 
 
No Generic Medicine available for this medicine.

Product Details

In Europe, Technivie is sold under the trade name Viekirax. Both brands are made by AbbVie.

Prescription Technivie contains the combination of ombitasvir, paritaprevir and ritonavir. Technivie is an antiviral medicine for the treatment of chronic hepatitis C. Technivie prevents the hepatitis virus from multiplying and infecting cells in your body, clearing your blood of the virus over time.
Paritaprevir and ombitasvir are protein blockers while ritonavir is classified as a booster as it prevents the breakdown of the active drug paritaprevir in the body.

Technivie is taken with other medicines such as Exviera (dasabuvir) and Copegus (ribavirin) as per your physicians instructions. Technivie interacts with many medicines so be sure to discuss all medicines, vitamins and herbs you are taking with your physician.

While you are taking Technivie, your doctor will be testing your blood to determine how well you are responding to the treatment.

The standard adult dose of Technivie is 2 tablets at one time in the morning with food. Swallow the tablets whole with water, do not crush, chew or break the tablets of Technivie. Children are not to be given Technivie. Do not stop taking Technivie unless your physician tells you, even if you feel well. You will have the best results if you continue taking Technivie for the duration prescribed. Do not miss a dose of Technivie, but if you do miss a dose and it is not more than 12 hours late, take as soon as you remember, if longer than 12 hours, skip that dose and continue the next day. Do not take double your regular dose of Technivie.

In 2019, when comparing Technivie to USA Technivie coupon price, InsulinHub was found to offer a discount of approximately 20% in Technivie savings. 

Buy Technivie from InsulinHub.com for the best Technivie cost.



Image Image Image Image